Hepatitis B virus reemerges with long-term nucleoside analog treatment, study suggests
Thursday, April 28, 2011 - 09:30
in Health & Medicine
A recently published study revealed that virological breakthrough (VBT) is common in patients receiving nucleoside analogs (NUCs) for chronic hepatitis B. Nearly 40% of the VBTs found were not related to antiviral drug resistance.
